Skip to Content
Contact DCTD
Show menu
Search this site
Last Updated: 03/15/2019

2019 American Association for Cancer Research (AACR) Annual Meeting

Schedule of DCTD Presentations

Several members of DCTD’s staff will present information at the AACR Annual Meeting External Link in Atlanta, GA, March 29 – April 3, 2019.

Oral Presentations

Time Title Presenter/Staff Authors Location
Saturday, March 30
5:30PM – 7:30 PM Careers in clinical and translational cancer research roundtable External Link James Doroshow, MD
Office of the Director
Percy Ivy, MD
Jeffrey Moscow, MD
Cancer Therapy Evaluation Program
Atrium Ballroom A
Marriott
Sunday, March 31
12:15PM – 1:45 PM The Cancer Moonshot: Rapid Launching of New Research Programs External Link Nita Seibel, MD
Malcolm Smith, MD, PhD
Percy Ivy, MD
Cancer Therapy Evaluation Program
Irina Lubensky, MD
Cancer Diagnosis Program
Room A406
1:00 PM – 2:45 PM Hyper-progression and immuno-oncology: Scientific, clinical, and regulatory challenges External Link Elad Sharon, MD, MPH
Cancer Therapy Evaluation Program
Room A402
4:05 PM – 4:20 PM A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) S1609: The neuroendocrine cohort External Link Helen Chen, MD
Elad Sharon, MD, MPH
Cancer Therapy Evaluation Program
Room A411
Tuesday, April 2
10:30 AM – 12:15 PM Funding Opportunities for Cancer Research at Multiple NIH Institutes and Centers External Link Julia Arnold, PhD Translational Research Program
Sundar Venkatachalam, PhD
Developmental Therapeutics Program
Room A406
12:30 PM – 2:15 PM Technology Transfer and Intellectual Property: Financial and Career Opportunities for Research Scientists External Link Jason Cristofaro, PhD, JD Room A406
3:00 PM – 5:00 PM Comparison of PDX, PDC, and PDOrg models from the National Cancer Institute’s Patient-Derived Models Repository (PDMR) External Link Yvonne Evrard, PhD
Developmental Therapeutics Program
Room A311
Wednesday, April 3
10:15 AM – 11:15 AM NCI-Supported Biospecimen Resources Available to the Cancer Research Community External Link Irina Lubensky, MD
Joanne Demchok, MS Cancer Diagnosis Program
Room A406

Poster Presentations

Time Title Location
Sunday, March 31
1:00 PM – 5:00 PM Molecular analysis for therapy choice (NCI-MATCH, EAY131) arm Z1B: Phase II trial of palbociclib for CCND1, 2 or 3 amplified tumors External Link Section 41; Abstract LB-010/2
1:00 PM – 5:00 PM Phase I trial of recombinant human interleukin 15 (rhIL-15) in combination with nivolumab and ipilimumab in refractory cancers External Link Section 41; Abstract LB-015/7
1:00 PM – 5:00 PM Temozolomide resistant MGMT negative/MMR proficient cancer cells rely on ATR signaling and homologous recombination for DNA repair and survival External Link Section 11; Abstract 270/14
Monday, April 1
8:00 AM – 12:00 PM Systemic establishment of robustness and standards in xenograft experiments and analysis External Link Section 4; Abstract 1054/5
8:00 AM – 12:00 PM Xenograft-associated B cell lymphoproliferative disease (XABLD) as a surrogate model to study Epstein-Barr virus (EBV) driven B cell diseases External Link Section 4; Abstract 1056/7
8:00 AM – 12:00 PM The PDX Data Commons and Coordinating Center (PDCCC) for PDXNet in support of preclinical research External Link Section 4; Abstract 1074/25
1:00 PM – 5:00 PM DNA damage response and therapeutic activity following once-daily administration of the Wee 1 inhibitor AZD1775 (adavosertib) External Link Section 16; Abstract CT099/23
1:00 PM – 5:00 PM Effect of 2D vs. 3D, exposure time, media and additives on growth and EGFR inhibitor response in patient-derived NSCLC lines External Link Section 13; Abstract 2170/21
1:00 PM – 5:00 PM A survey of molecular factors of DNA methylation and demthylation in a broad range of cancer cell lines External Link Section 31; Abstract 2479/19
1:00 PM – 5:00 PM MutSpliceDB: A database of splice sites mutations effects External Link Section 31; Abstract 2480/20
Tuesday, April 2
8:00 AM – 12:00 PM NCI-MATCH EAY131 -Z1I: Phase II study of AZD1775, a wee-1 kinase inhibitor, in patients with tumors containing BRCA1 and BRCA2 mutations External Link Section 16; Abstract CT138/4
8:00 AM – 12:00 PM NCI Molecular Analysis for Therapy Choice (NCI-MATCH EAY131) arm B: Phase II study of afatinib in patients (pts) with HER2 (ERBB2) activation mutations External Link Section 16; Abstract CT139/5
8:00 AM – 12:00 PM Lymphoblast cells secrete putative protein factors in response to high-dose radiation causing anti-tumor effect in lung cancer cells External Link Section 8; Abstract 2920/8
8:00 AM – 12:00 PM Comparison of genomic biomarkers identified by the whole exome, RNASeq and whole genome sequencing pipelines developed for the PDMR External Link Section 31; Abstract 3385/16
1:00 PM – 5:00 PM In vivo evaluation of the Menin inhibitor VTP-50469 against Ewing sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC) External Link Section 11; Abstract 3835/10
1:00 PM – 5:00 PM Comparison of thio-deoxy-cytidine (TdCyd) and aza-thio-deoxy-cytidine (Aza-TdCyd) in solid and liquid tumor cell lines and PPTC pediatric xenografts External Link Section 11; Abstract 3839/14
1:00 PM – 5:00 PM Knockout of DNMT1 using CRISPR gene-editing technology confers resistance to DNMT inhibitors in human breast cancer cells External Link Section 11; Abstract 3847/22
1:00 PM – 5:00 PM In vivo evaluation of the LSD1 inhibitor SP-2577 against Ewing sarcoma and rhabdomyosarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC) External Link Section 11; Abstract 3848/23
1:00 PM – 5:00 PM Association of transcriptional levels of folate-mediated one-carbon metabolism related genes in cancer cell lines with drug treatment response External Link Section 29; Abstract 4246/15
Wednesday, April 3
8:00 AM – 12:00 PM A phase II trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed metastatic colorectal carcinoma External Link Section 41; Abstract LB-293/10

Meet-the-Expert Presentations — NCI Exhibit Booth #2111

Time Topic Presenter
Sunday, March 31
3:00 – 3:30 PM NCI’s Cancer Complementary and Alternative Medicine Programs Libin Jia, MD
Office of Cancer Complementary and Alternative Medicine
3:30 – 4:00 PM SPOREs: 25 Years of Translational Team Research at the NCI Julia Arnold, PhD
Translational Research Program
Monday, April 1
11:30 AM – 12:00 PM In Vitro and In Vivo Models from the NCI Patient-Derived Models Repository Yvonne Evrard, PhD
Developmental Therapeutics Program
2:00 – 2:30 PM Funding Opportunity for Advancing Cancer Immunotherapy by Mitigating Immune-related Adverse Events (irAE) Elad Sharon, MD, MPH
Cancer Therapy Evaluation Program
3:00 – 3:30 PM Future of NCI-MATCH Trial Lyndsay Harris, MD
Cancer Diagnosis Program
3:30 – 4:00 PM The NCI Formulary: A Cancer Moonshot Initiative Jason Cristofaro, PhD, JD
Office of the Director
Tuesday, April 2
11:30 AM – 12:00 PM New NCI Resources for Development of Immunotherapy Products Connie Sommers, PhD
Developmental Therapeutics Program
2:00 – 2:30 PM The NCI Molecular Characterization Laboratory: Activities and Resources Available Chris Karlovich, PhD
Developmental Therapeutics Program
2:30 – 3:00 PM Cancer Diagnosis Programs and Funding Opportunities Aniruddha Ganguly, PhD
Cancer Diagnosis Program
3:30 – 4:00 PM Radiation Research Program Pat G. Prasanna, PhD
Mansoor M. Ahmed, PhD
Radiation Research Program

DCTD Staff Kiosk Schedule — Cancer Treatment and Diagnosis — NCI Exhibit Booth #2111

Time DCTD Staff
Sunday, March 31
1:00 – 3:00 PM Aniruddha Ganguly, PhD
Cancer Diagnosis Program
Timothy Hefferon, PhD
NLM/National Center for Biotechnology Information
3:00 – 5:00 PM Leah Hubbard, PhD
Translational Research Program
Monday, April 1
9:00 – 11:00 AM Sudhir Kondapaka, PhD
Developmental Therapeutics Program
11:00 AM – 1:00 PM Yali Fu, PhD
Developmental Therapeutics Program
1:00 – 3:00 PM Beverly Teicher, PhD
Developmental Therapeutics Program
Timothy Hefferon, PhD
NLM/National Center for Biotechnology Information
3:00 – 5:00 PM Steve Nothwehr, PhD
Translational Research Program
Tuesday, April 2
9:00 – 11:00 AM Weiwei Chen, PhD
Developmental Therapeutics Program
11:00 AM – 1:00 PM Nina Lukinova, PhD
Cancer Diagnosis Program
1:00 – 3:00 PM Rose Aurigemma, PhD
Developmental Therapeutics Program
3:00 – 5:00 PM Joanne Demchok, MS
Cancer Diagnosis Program
Wednesday, April 3
9:00 AM – 12:00 PM Aniruddha Ganguly, PhD
Cancer Diagnosis Program